NKL22 is primarily utilized in the field of biomedical research, particularly in studies focused on cancer therapy. It is investigated for its potential role in inhibiting specific pathways that contribute to tumor growth and metastasis. Researchers are exploring its efficacy in targeting certain proteins or receptors involved in cancer cell proliferation, making it a candidate for developing novel anticancer drugs. Additionally, NKL22 is being studied for its possible applications in immunotherapy, where it may enhance the body's immune response against cancer cells. Its use is still largely experimental, with ongoing studies to determine its safety, dosage, and effectiveness in clinical settings.